ACADIA Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACAD and other ETFs, options, and stocks.About ACAD
ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.
ACAD Key Statistics
Stock Snapshot
As of today, ACADIA Pharmaceuticals(ACAD) shares are valued at $30.17. The company's market cap stands at 5.2B, with a P/E ratio of 13.59.
On 2026-08-19, ACADIA Pharmaceuticals(ACAD) stock moved within a range of $29.77 to $30.96. With shares now at $30.17, the stock is trading +1.3% above its intraday low and -2.6% below the session's peak.
Trading volume for ACADIA Pharmaceuticals(ACAD) stock has reached 1.15M, versus its average volume of 2.06M.
The stock's 52-week range extends from a low of $19.69 to a high of $30.96.
The stock's 52-week range extends from a low of $19.69 to a high of $30.96.
ACAD News
In August 2026, ACADIA Pharmaceuticals Inc. reported past second-quarter 2026 results showing revenue of US$307.96 million and net income of US$31.5 million, wi...
UBS raised the firm’s price target on Acadia Pharmaceuticals (ACAD) to $49 from $45 and keeps a Buy rating on the shares. Acadia is viewed favorably ahead of re...
Analyst ratings
76%
of 21 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.